Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

Jacques Broodryk: Trump hits SA officials with “bombshell” visa restrictions

In this interview with Chris Steyn, Jacques Broodryk, the Chief Spokesperson for Community Safety at AfriForum, hails the announcement by the Trump administration of visa restrictions for those “responsible for, or complicit in, the enactment or implementation of laws or policies that enable uncompensated land seizures, race-based discrimination, and/or the…
16 Sep 7AM 16 min

Leon Kluge: The botanist turning South Africa's flowers into gold

Leon Kluge pulled off a hat-trick no South African had managed before: three straight gold medals at the Chelsea Flower Show, the world's most prestigious garden show. But this year's win very nearly didn't happen. Storms and flooding tore through the Western Cape days before the harvest, cutting farmers off…
15 Sep 12PM 42 min